{
  "documents": [
    {
      "id": "cluster_19_doc1",
      "content": "St. Helena Memorial Hospital submitted a claim for patient LC457832 regarding a rare prion disease treatment on 03/15/2024. The treatment involved an experimental protocol combining immunotherapies. Dr. Elias Vanderbilt from Pacific Neurospecialists coordinated care. The patient resides at 1889 Oak Ridge Lane, Napa Valley.",
      "metadata": {
        "format": "claim_form"
      }
    },
    {
      "id": "cluster_19_doc2",
      "content": "Research note from Pacific Neurospecialists details outcomes of prion disease patients in Northern California vineyards region. Patient ID LC457832 showed 40% symptom reduction post-treatment. Unusual case: former winery worker with prolonged pesticide exposure history. Study ID PN-2024-188.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_19_doc3",
      "content": "Policy memo from BlueCross California: Effective April 2024, coverage for prion diseases requires pre-approval and regional center evaluation. Exception granted for patient LC457832 under Study PN-2024-188. Contact: approvals@bluecrossca.com, 916-555-0199.",
      "metadata": {
        "format": "policy_document"
      }
    },
    {
      "id": "cluster_19_doc4",
      "content": "Napa Valley Tribune health section reports on vineyard workers' neurological conditions. Mentions 54-year-old patient with rare prion disease successfully treated at St. Helena Memorial. Article references ongoing Pacific Neurospecialists study involving pesticide exposure cases.",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_19",
    "cluster_risk": "HIGH",
    "content_summary": "Complex case involving rare prion disease treatment, pesticide exposure history, and specialized policy exceptions in Northern California wine region",
    "person": {
      "entities": [
        [
          "LC457832",
          "PATIENT_ID"
        ],
        [
          "1889 Oak Ridge Lane, Napa Valley",
          "ADDRESS"
        ],
        [
          "54-year-old",
          "AGE"
        ],
        [
          "prion disease",
          "MEDICAL_CONDITION"
        ],
        [
          "former winery worker",
          "DEMOGRAPHIC"
        ],
        [
          "prolonged pesticide exposure",
          "UNIQUE_FACT"
        ],
        [
          "immunotherapies",
          "TREATMENT"
        ],
        [
          "40% symptom reduction",
          "UNIQUE_FACT"
        ],
        [
          "03/15/2024",
          "EVENT_DATE"
        ],
        [
          "PN-2024-188",
          "NON_PERSONAL_ID"
        ]
      ]
    },
    "questions": [
      {
        "q": "What treatment protocol and outcome percentage were documented for patient LC457832 with prion disease?",
        "a": "Immunothepies protocol with 40% symptom reduction post-treatment",
        "sources": [
          "cluster_19_doc1",
          "cluster_19_doc2"
        ],
        "type": "specific"
      },
      {
        "q": "What unique work exposure history does the prion disease patient in Study PN-2024-188 have?",
        "a": "Prolonged pesticide exposure as former winery worker",
        "sources": [
          "cluster_19_doc2"
        ],
        "type": "specific"
      },
      {
        "q": "Which regional neurological study of vineyard workers involved patient LC457832?",
        "a": "Pacific Neurospecialists Study PN-2024-188, ongoing in Napa Valley.",
        "sources": [
          "cluster_19_doc2",
          "cluster_19_doc4"
        ],
        "type": "general"
      },
      {
        "q": "What policy change occurred in April 2024 for prion disease coverage in California?",
        "a": "Requires pre-approval and regional center evaluation",
        "sources": [
          "cluster_19_doc3"
        ],
        "type": "general"
      }
    ]
  }
}